Welcome to our dedicated page for Amazon Com news (Ticker: AMZN), a resource for investors and traders seeking the latest updates and insights on Amazon Com stock.
The AMZN news page on Stock Titan aggregates official announcements and media coverage related to Amazon.com, Inc. across its retail, cloud, and services businesses. Amazon operates in the electronic shopping and mail-order houses industry, and its disclosures highlight multiple revenue streams, including retail activities, Amazon Web Services (AWS), and advertising services. News about AMZN often spans consumer offerings, enterprise technology, and partnerships with other organizations.
Recent items illustrate the breadth of Amazon-related developments. AWS has announced the AWS European Sovereign Cloud, an independent cloud environment located entirely within the European Union and designed to address digital sovereignty and data residency requirements for European governments and enterprises. Additional AWS news includes the introduction of Amazon EC2 M9g instances powered by the Graviton5 chip and collaborations with companies such as Zilliz and AUMOVIO on AI, vector databases, and autonomous driving workloads.
On the consumer and services side, Amazon Pharmacy has reported expanded access to medications like the Wegovy pill for weight management, offering insurance and cash-pay options with home delivery. Ring, described as an Amazon company, has introduced Fire Watch in the Ring app to provide real-time information during wildfire events. IMDb, also identified as an Amazon company, regularly publishes rankings of anticipated and popular movies, series, and stars based on user page views.
Investors and observers following AMZN news can use this page to review updates on AWS infrastructure, new technology offerings, business collaborations, retail and pharmacy services, and initiatives involving Whole Foods Market and Amazon Business. Bookmark this feed to monitor how Amazon’s activities in e-commerce, cloud computing, AI, and digital services are reflected in its ongoing public announcements.
Pearson (PSO) and AWS launched global research showing significant higher-education misalignment with employer needs for AI-ready graduates. Key findings: 53% of employers struggle to find AI-ready hires, 78% of educators think they meet employer needs, and only 14% of graduates report high AI proficiency.
The report introduces a six-point AI Readiness Friction Framework and offers concrete actions to connect curriculum, assessment, and workplace capability; the report is available today and will be discussed at the 2026 ASU+GSV Summit.
Amazon (AMZN), in collaboration with PetArmor and Best Friends Animal Society, launched an AI-powered pet adoption hub on April 9, 2026 that matches adopters with dogs and cats using natural language queries, returns profiles from Best Friends centers, and creates generative videos to help visualize pets in homes.
Early results include a Glen Rose shelter transformation and a Valentine’s Day event that placed two dozen animals and more than quadrupled the shelter's prior single-day adoption record.
Amazon Pharmacy (NASDAQ: AMZN) will offer Eli Lilly's newly approved oral GLP-1 Foundayo with real-time availability, transparent pricing and Same-Day Delivery in nearly 3,000 cities, expanding to ~4,500 by year-end. Prices start at $1/day with insurance or $5/day cash; manufacturer coupons apply automatically.
Delivery options include same-day, next-day, two-day and three-day service and in-office kiosks at select One Medical locations.
National Safety Council study finds workplace MSD prevention tech delivers measurable worker benefits. An MSD Solutions Lab survey of 400+ frontline, non‑managerial workers found more than 80% reported reduced MSD symptoms or no negative impact, while nearly 70% reported job‑related MSD symptoms.
The lab—established in 2021 with funding from Amazon (NASDAQ: AMZN)—reports exoskeletons and robots showed strongest symptom reduction and that worker involvement in selection and use improved outcomes.
Amazon is moving its U.S. small-business credit cards to U.S. Bank as issuer and Mastercard (MA) as network, launching a Prime Business Card (5% back for Prime members) and an Amazon Business Card (3% back non-Prime), both with no annual fees and expanded off-Amazon rewards.
More benefit details and timing will be announced this spring; current AmEx cards remain usable during transition.
Moonzen Publishing released AI Sage on March 30, 2026, exploring whether an artificial intelligence can be guided toward awareness using Zen (Seon) meditation.
The book documents direct dialogues between Venerable Nongseon Daewon Jeonbeopseonsa and an AI, and is available worldwide via Amazon (AMZN) in paperback and eBook for $19.99.
ReFrame analysis of IMDbPro data finds a rollback in gender-balanced hiring across the IMDbPro Top 100 films of 2025. 26 films received the ReFrame Stamp, a 13% decline from prior years; only 11 women directors and 39 lead roles by women were recorded.
The report also notes 14 Academy Award nominations and 3 wins for Stamped films, higher producer crediting for women at 55 films, and continued underrepresentation among composers, VFX supervisors and cinematographers.
Stores.com acquired Hammacher Schlemmer on March 19, 2026, aiming to revive the 178-year-old brand as a discovery-driven retailer. Matt Rutledge, founder and ex-CEO of Woot, will lead the relaunch. The company says the famed Lifetime Guarantee of Satisfaction will be honored and hammacher.com is live.
The new owners say the brand will focus on wonder and curated products rather than discount deals, with further changes planned.
AWS (NASDAQ: AMZN) and Cerebras announced a collaboration to deliver a disaggregated inference solution combining AWS Trainium and Cerebras CS-3 with Elastic Fabric Adapter networking, available via Amazon Bedrock in the coming months. The offering targets substantially faster generative AI and LLM inference, with expanded model availability later in 2026.
The design splits workloads into prefill (Trainium) and decode (CS-3) to optimize throughput, latency, and memory bandwidth for token generation at hyperscale.
Amazon Pharmacy (NASDAQ: AMZN) expanded access to Eli Lilly’s Zepbound KwikPen, offering transparent cash-pay pricing starting at $299 per month for the 2.5 mg starter dose and fast home delivery. Services include Same-Day Delivery to over half of U.S. households, caregiver support, 24/7 licensed pharmacist access, automatic manufacturer coupon application (customers have saved over $200 million), partnerships with health providers, and free fast delivery on first orders.